NVO241220C136000
- 0.01
- -0.06-85.71%
Novo-Nordisk A/S Newsroom
Novo-Nordisk A/S (NVO.US) is investing 1.2 billion USD to build a new factory in Odense, Denmark, expected to be completed in 2027.
Novo-Nordisk A/S will invest 8.5 billion Danish Kroner (approximately 1.2 billion US dollars) to build a large factory in Denmark to meet the growing market demand for its blockbuster Pharmaceuticals.
Express News | Novo-Nordisk A/S acquisition of Catalent Trade has been approved for completion.
Sector Update: Health Care Stocks Decline Monday Afternoon
Novo-Nordisk A/S (NVO.US) invests 1.2 billion USD to build a factory for rare disease drugs in Denmark.
The Danish pharmaceutical company Novo-Nordisk A/S (NVO.US) announced on Monday that it will invest 8.5 billion kroner (approximately 1.2 billion USD) to build a new factory in Odense, Denmark, for the production of drugs for rare diseases. The company stated that construction work has already begun and is expected to be completed by 2027, at which time the facility is projected to create 400 permanent jobs.
Top Midday Stories: Honeywell Mulls Separation of Aerospace Business; Starbucks Expands Parental Leave for US Store Workers
Why the Investor Craze for Ozempic and Rival Weight-loss Drugs May Resume Next Year
Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent
Research finds that Novo-Nordisk A/S's (NVO.US) weight loss drugs may cause "blindness"; Danish regulatory authorities seek an investigation.
The Danish Pharmaceutical Agency stated that it will require European authorities to review two new studies indicating a link between Novo-Nordisk A/S's best-selling drug Ozempic and a rare loss of vision.
Novo Nordisk's Imminent Capacity Increase Is a Significant Positive -- Market Talk
Novo Nordisk to Invest $1.2 Billion in New Plant in Denmark
Novo Nordisk: Construction Work Has Commenced, Scheduled to Be Completed in 2027
Express News | Market news: Novo-Nordisk A/S is investing 8.5 billion Danish kroner to establish a new production facility in Odense, Denmark.
Novo Nordisk Invests DKK 8.5 Billion in New Production Facility in Odense, Denmark
Futu Morning News | Ready for the "Federal Reserve Decision Day"! More than 20 central banks from various countries will hold meetings this week; the adjustment of Nasdaq 100 constituents will take effect next week! Palantir and MSTR have been included.
This week's highlights from the Federal Reserve: There's no doubt about a rate cut in December, but January remains uncertain; Tesla's stock rose over 4% to a new high, and reports indicate that Trump's team is seeking to abolish the requirement for accident reports for autonomous vehicles.
Express News | Novo-Nordisk A/S: All regulatory completion conditions for Novo Holdings' acquisition of Cantel Medical for 16.5 billion USD have been met.
Key Deals for the Week: Patterson, Hershey & Mondelez, AIG & Nippon and More
Express News | Zhang Ligang from Ai Kang Group stated that most entrepreneurs are overweight because they lack time for exercise and drink a lot.
Express News | Novo-Nordisk A/S: It is expected that no Share Buyback plan will be initiated in 2025.
U.S. stock market close | The Nasdaq 100 has risen for four consecutive weeks, Tesla's stock increased by over 4% reaching a new historical high, Broadcom surged over 24% after earnings with a market cap surpassing one trillion dollars.
The three major U.S. stock indexes closed mixed, with the Dow Jones falling for the seventh consecutive Trade day, marking the longest losing streak since 2020, as investors expect the Federal Reserve to slow the pace of interest rate cuts next week.
CFRA Initiates Novo-Nordisk A/S(NVO.US) With Hold Rating, Announces Target Price $122